Histogen Inc Asset Turnover Ratio (HSTO), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Histogen Inc   (HSTO)
 

Histogen Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Histogen Inc has not recorded any assets.
Visit Histogen Inc Balance sheet

Within sector 219 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 3560, from total ranking in the second quarter 2023 at 3919.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HSTO Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -69.08 % -45.06 % -58.71 % -33.81 % -21.83 %
Y / Y Revenue Change 0 % 0 % -99.87 % -20 % -99.15 %
Asset Turnover Ratio (TTM) 0 0 0 0.18 0.16
HSTO's Total Ranking # 3560 # 3919 # 3919 # 4032 # 3919
Seq. Asset Change -39.62 % -25.93 % -18.16 % -15.52 % 7.26 %
Seq. Revenue Change 0 % 0 % 25 % -20 % 0 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 220
Healthcare Sector # 607
Overall Market # 3560

Asset Turnover Ratio Statistics
High Average Low
56.65 20.37 0.27
(Jun 30 2020)   (Mar 31 2023)




HSTO Company Profile • Back to HSTO Efficiency Comparisons • Compare HSTO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Akili Inc   0.01 $ 1.040  Millions$ 118.440  Millions
Fusion Pharmaceuticals Inc   0.01 $ 2.208  Millions$ 251.819  Millions
Singular Genomics Systems Inc   0.01 $ 2.595  Millions$ 300.484  Millions
Envoy Medical Inc   0.01 $ 0.241  Millions$ 28.684  Millions
Axim Biotechnologies Inc   0.01 $ 0.034  Millions$ 4.136  Millions
Synlogic Inc   0.01 $ 0.708  Millions$ 87.462  Millions
Shattuck Labs Inc   0.01 $ 1.333  Millions$ 167.182  Millions
Bioxcel Therapeutics Inc   0.01 $ 1.242  Millions$ 156.626  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 10.475  Millions
Traws Pharma inc   0.01 $ 0.217  Millions$ 32.985  Millions
Century Therapeutics inc   0.01 $ 2.488  Millions$ 439.371  Millions
Aim Immunotech Inc   0.01 $ 0.194  Millions$ 34.857  Millions
Serina Therapeutics Inc   0.01 $ 0.056  Millions$ 10.065  Millions
Pluri Inc 0.00 $ 0.254  Millions$ 54.911  Millions
Chimerix Inc 0.00 $ 1.134  Millions$ 251.060  Millions
Sera Prognostics Inc 0.00 $ 0.330  Millions$ 102.169  Millions
Inmune Bio Inc 0.00 $ 0.224  Millions$ 72.048  Millions
Rafael Holdings Inc 0.00 $ 0.277  Millions$ 102.252  Millions
China Health Industries Holdings Inc 0.00 $ 0.115  Millions$ 46.692  Millions
Lexicon Pharmaceuticals Inc 0.00 $ 0.531  Millions$ 237.555  Millions
Ovid Therapeutics Inc 0.00 $ 0.296  Millions$ 139.973  Millions
Inhibrx Biosciences Inc 0.00 $ 0.440  Millions$ 282.624  Millions
Immunitybio inc 0.00 $ 0.556  Millions$ 357.350  Millions
Histogen Inc 0.00 $ 0.019  Millions$ 13.621  Millions
Ataibeckley Inc 0.00 $ 0.335  Millions$ 286.993  Millions
Viridian Therapeutics Inc 0.00 $ 0.347  Millions$ 375.489  Millions
Geron Corporation 0.00 $ 0.317  Millions$ 360.941  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.